SELLAS Life Sciences Group, Inc. (SLS) Tops Q3 EPS by 3c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q3 EPS of ($0.10), $0.03 better than the analyst estimate of ($0.13).

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Advance Auto Parts falls on revenue miss, weak guidance
• DelphX launches private placement targeting up to C$50,000